Needham & Company
-
Notable 52-Week Highs and Lows 3/13: (AMRN) (NXPI) (BMRN) High; (CTIC) (GALE) (HERO) Low
-
Galena Biopharma (GALE) PT Lowered at Needham & Company But Still Sees Shares Doubling
-
Galena Biopharma (GALE) Buy Reiterated at Needham & Company Posts Q1 on Pipeline Progress
-
GALENA BIOPHARMA (GALE) Presenting at 13th Annual Needham Healthcare Conference
-
Galena Biopharma to Present at the 13th Annual Needham Healthcare Conference
-
Pre-Open Stock Movers 3/19: (HZNP) (PRTA) (KBH) Higher; (RENN) (RBCN) (KNDI) (ORCL) Lower (more...)
-
After Hours Stock Movers 3/18: (PRTA) (EXAS) (PSUN) Higher; (RBCN) (ORCL) (NUS) Lower (more...)
-
Needham & Company Defends Galena Biopharma (GALE)
-
Unusual 11 Mid-Day Movers 03/18: (GERN) (XGTI) (BGMD) Higher; (GGS) (KIOR) ETAK) Lower
-
Pre-Open Stock Movers 2/3: (KTOS) (PGNX) (ARTC) Higher; (UNTD) (GALE) (SFY) Lower (more...)
-
Galena Biopharma (GALE) Target Lifted to $9 at Needham & Company
-
Pre-Open Stock Movers 9/13: (ULTA) (GSVC) (OCLR) Higher; (GALE) (ARTX) (INN) Lower (more...)
-
Notable 52-Week Highs and Lows of the Day 04/29: (HCA) (SPWR) (GALE) High; (AUXL) (AEM) Low
-
Notable Analyst Rating Changes 03/25: (KBH) (DRI) (ARRY) Upgraded; (BBRY) (TXT) (JCP) Downgraded
-
StreetInsider.com Pre-Open Movers 03/25: (APOL) (DG) (DELL) Higher; (OTT) (IDIX) (BBRY) Lower (more...)
-
Needham & Company Starts Galena Biopharma (GALE) at Buy
-
Notable Analyst Rating Changes 12/31: (FB) (PMFG) (BMY) Upgraded; (FOE) Downgraded

